KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Astrazeneca (AZN) Times Interest Earned (2016 - 2025)

Historic Times Interest Earned for Astrazeneca (AZN) over the last 16 years, with Q4 2025 value amounting to -$6.15.

  • Astrazeneca's Times Interest Earned fell 2964.59% to -$6.15 in Q4 2025 from the same period last year, while for Dec 2025 it was -$8.06, marking a year-over-year decrease of 4028.8%. This contributed to the annual value of -$8.11 for FY2025, which is 4128.17% down from last year.
  • Per Astrazeneca's latest filing, its Times Interest Earned stood at -$6.15 for Q4 2025, which was down 2964.59% from -$8.26 recorded in Q3 2025.
  • Astrazeneca's Times Interest Earned's 5-year high stood at $70.19 during Q1 2021, with a 5-year trough of -$10.53 in Q1 2025.
  • For the 5-year period, Astrazeneca's Times Interest Earned averaged around -$0.75, with its median value being -$4.68 (2024).
  • Per our database at Business Quant, Astrazeneca's Times Interest Earned surged by 200995.75% in 2021 and then tumbled by 44968.04% in 2022.
  • Over the past 5 years, Astrazeneca's Times Interest Earned (Quarter) stood at $0.87 in 2021, then crashed by 449.68% to -$3.04 in 2022, then grew by 8.75% to -$2.77 in 2023, then tumbled by 71.15% to -$4.75 in 2024, then dropped by 29.65% to -$6.15 in 2025.
  • Its Times Interest Earned stands at -$6.15 for Q4 2025, versus -$8.26 for Q3 2025 and -$7.99 for Q2 2025.